Although biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and the cell-cycle arrest marker panel TIMP-2×IGFBP7 can detect subclinical AKI earlier than creatinine, their clinical utility remains limited. Here, TIMP1 is linked to acute kidney injury.